In latency II malignancies, such as Hodgkin lymphoma, nasopharyngeal carcinoma, and NK/T cell lymphoma, LMP-1-mediated activation of PI3K/AKT and JAK/STAT pathways is believed to be the main oncogenic event [43]. This evidence concerns the gene PDLIM7 and Hodgkins lymphoma.